FINTEPLA sol 2.2 mg/ml buvable fl 360 ml
7680693710023
CH-69371
N03AX26
01.07.1.
1 / 3
google
Details
- GTIN
- 7680693710023
- Pharmacode
- -
- Product number
- 6937101
- CPT
- -
- Packaging group
- 360 ml
- Unit
- Flasche(n)
- Composition
- fenfluraminum 2.2 mg ut fenfluramini hydrochloridum, E 219 2.3 mg, E 215 0.23 mg, sucralosum, hydroxyethylcellulosum cum natrii dihydrogenophosphas et dinatrii phosphas, kalii citras, acidum citricum monohydricum, aromatica cerise cum glucosum, ethylis benzoas, maltodextrinum et E 220, aqua ad iniectabile ad solutionem pro 1 ml corresp. natrium 0.33 mg.
Articles (1)
Fintepla 2.2 mg/ml, solution buvable
Lösung
360 ml
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
fenfluraminum
|
2.2 MG | Substance | Wirkstoff (Principe actif) |
|
fenfluramini hydrochloridum
|
- | Substance | WIZUS |
|
E 219
|
2.3 MG | Substance | HBESI |
|
E 215
|
0.23 MG | Substance | HBESI |
|
sucralosum
|
- | Substance | HNIDK |
|
hydroxyethylcellulosum
|
- | Substance | HNIDK |
|
natrii dihydrogenophosphas
|
- | Substance | HNIDK |
|
dinatrii phosphas
|
- | Substance | HNIDK |
|
kalii citras
|
- | Substance | HNIDK |
|
acidum citricum monohydricum
|
- | Substance | HNIDK |
|
aromatica
|
- | Substance | AROMA |
|
glucosum
|
- | Substance | HBESI |
|
ethylis benzoas
|
- | Substance | HBESI |
|
maltodextrinum
|
- | Substance | HNIDK |
|
E 220
|
- | Substance | HBESI |
|
aqua ad iniectabile
|
- | Substance | HNIDK |
|
natrium
|
0.33 MG | Substance | HBESI |
Authorization holder
UCB-Pharma SA
1630 Bulle
Authorization information
- Swissmedic authorization number
- 69371
- Drug name
- Fintepla, solution buvable
- Galenic form
- LSOR
- ATC Code
- N03AX26
- Authorization status
- Z
- Dispensation category
- A
- First authorization
- 13/02/2025
- Authorization expiration date
- 12/02/2030
- IT number
- 01.07.1.
- Domain
- Human medicine
Packaging details
- Description (FR)
- FINTEPLA sol 2.2 mg/ml buvable fl 360 ml
- Description (DE)
- FINTEPLA Lös 2.2 mg/ml zum Einnehmen Fl 360 ml
- Market launch
- 13/02/2025
- Narcotic (BTM)
- No